Insider Trading30 Sept 2026, 04:03 pm
Novelix Pharma Closes Trading Window for Insider Trading
AI Summary
Novelix Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their relatives. This closure will be effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. The company has directed all designated persons and insiders to refrain from trading in the company's securities during this period, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from October 1, 2026.
- Period extends 48 hours post financial results declaration.
- Compliance with SEBI PIT Regulations, 2015.
- Insiders are prohibited from trading during closure.
Price Impact
More from NOVELIX